真菌性脑膜炎

Johnson RH, Einstein HE. Coccidioidal meningitis. Clin Infect Dis. 2006;42:103-107.

• 全文
• 摘要

Beale MA, Sabiiti W, Robertson EJ, et al. Genotypic diversity is associated with clinical outcome and phenotype in cryptococcal meningitis across Southern Africa. PLoS Negl Trop Dis. 2015;9:e0003847.

• 全文
• 摘要

Jarvis JN, Bicanic T, Loyse A, et al. Determinants of mortality in a combined cohort of 501 patients with HIV-associated cryptococcal meningitis: implications for improving outcomes. Clin Infect Dis. 2014;58:736-745.

• 全文
• 摘要

Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin North Am. 2006;20:507-544.

• 摘要

Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45:807-825.

• 全文
• 摘要

Galgiani JN, Ampel NM, Blair JE, et al. 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis. 2016;63:e112-e146.

• 全文
• 摘要

Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62:e1-e50.

• 全文
• 摘要

Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:291-322.

• 全文
• 摘要

Muller M, Wandel S, Colebunders R, et al. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10:251-261.

• 摘要

Yuanije Z, Jianghan C, Nan X, et al. Cryptococcal meningitis in immunocompetent children. Mycoses. 2012;55:168-171.

• 摘要

Day JN, Chau TT, Wolbers M, et al. Combination antifungal therapy for cryptococcal meningitis. N Engl J Med. 2013;368:1291-1302.

• 全文
• 摘要

Boulware DR, Meya DB, Muzoora C, et al; COAT Trial Team. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. N Engl J Med. 2014;370:2487-2498.

• 全文
• 摘要

1.  Kravitz GR, Davies SF, Eckman MR, et al. Chronic blastomycotic meningitis. Am J Med. 1981;71:501-505.

• 摘要

2.  Harley WB, Lomis M, Haas DW. Marked polymorphonuclear pleocytosis due to blastomycotic meningitis: a case report and review Clin Infect Dis. 1994;18:816-818.

• 摘要

3.  Scott EN, Kaufman L, Brown AC, et al. Serologic studies in the diagnosis and management of meningitis due to Sporothrix schenckii. N Engl J Med. 1987;317:935-940.

• 摘要

4.  Salaki JS, Louria DB, Chmel H. Fungal and yeast infections of the central nervous system. A clinical review. Medicine (Baltimore). 1984;63:108-132.

• 摘要

5.  Ellner JJ, Bennett JE. Chronic meningitis. Medicine (Baltimore). 1976;55:341-369.

• 摘要

6.  Gottfredsson M, Perfect JR. Fungal meningitis. Semin Neurol. 2000;20:307-322.

• 摘要

7.  Kauffman CA. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev. 2007;20:115-132.

• 全文
• 摘要

8.  Wheat LJ. Histoplasmosis: a review for clinicians from non-endemic areas. Mycoses. 2006;49:274-282.

• 摘要

9.  Saubolle MA, McKellar PP, Sussland D. Epidemiologic, clinical and diagnostic aspects of coccidioidomycosis. J Clin Microbiol. 2007;45:26-30.

• 全文
• 摘要

10.  Johnson RH, Einstein HE. Coccidioidal meningitis. Clin Infect Dis. 2006;42:103-107.

• 全文
• 摘要

11.  Jenney A, Pandithage K, Fisher DA, et al. Cryptococcus infection in tropical Australia. J Clin Microbiol. 2004;42:3865-3868.

• 全文
• 摘要

12.  MacDougall L, Kidd SE, Galanis E, et al. Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA. Emerg Infect Dis. 2007;13:42-50.

• 全文
• 摘要

13.  Beale MA, Sabiiti W, Robertson EJ, et al. Genotypic diversity is associated with clinical outcome and phenotype in cryptococcal meningitis across Southern Africa. PLoS Negl Trop Dis. 2015;9:e0003847.

• 全文
• 摘要

14.  Mirza SA, Phelan M, Rimland D, et al. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis. 2003;36:789-794.

• 全文
• 摘要

15.  Holmes CB, Losina E, Walensky RP, et al. Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa. Clin Infect Dis. 2003;36:652-662.

• 全文
• 摘要

16.  Chariyalertsak S, Sirisanthana T, Saengwonloey O, et al. Clinical presentation and risk behaviours of patients with acquired immunodeficiency syndrome in Thailand, 1994-1998: regional variation and temporal trends. Clin Infect Dis. 2001;32:955-962.

• 全文
• 摘要

17.  Jarvis JN, Bicanic T, Loyse A, et al. Determinants of mortality in a combined cohort of 501 patients with HIV-associated cryptococcal meningitis: implications for improving outcomes. Clin Infect Dis. 2014;58:736-745.

• 全文
• 摘要

18.  Hakim JG, Gangaidzo IT, Heyderman RS, et al. Impact of HIV infection on meningitis in Harare: a prospective study of 406 predominantly adult patients. AIDS. 2000;14:1401-1407.

• 摘要

19.  Gordon SB, Walsh AL, Chaponda M, et al. Bacterial meningitis in Malawian adults: pneumococcal disease is common, severe and seasonal. Clin Infect Dis. 2000;31:53-57.

• 全文
• 摘要

20.  Hajjeh RA, Conn LA, Stephens DS, et al. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. J Infect Dis. 1999;179:449-454.

• 全文
• 摘要

21.  Safdieh JE, Mead PA, Sepkowitz KA, et al. Bacterial and fungal meningitis in patients with cancer. Neurology. 2008;70:943-947.

• 摘要

22.  MacDougall L, Fyfe M. Emergence of Cryptococcus gattii in a novel environment provides clues to its incubation period. J Clin Microbiol. 2006;44:1851-1852.

• 全文
• 摘要

23.  Hoang LM, Maguire JA, Doyle P, et al. Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997-2002): epidemiology, microbiology and histopathology. J Med Microbiol. 2004;53:935-940.

• 全文
• 摘要

24.  Edwards LB, Acquaviva FA, Livesay VT, et al. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Annu Rev Respir Dis. 1969;99(Suppl):1-132.

• 摘要

25.  Wheat LJ, Musial CE, Jenny-Avital E. Diagnosis and management of central nervous system histoplasmosis. Clin Infect Dis. 2005;40:844-852.

• 全文
• 摘要

26.  Chiller TM, Galgani JN, Stevens DA. Coccidioidomycosis. Infect Dis Clin North Am. 2003;17:41-57.

• 摘要

27.  DiCaudo DJ. Coccidioidomycosis: a review and update. J Am Acad Dermatol. 2006;55:929-942.

• 摘要

28.  Centers for Disease Control and Prevention. Coccidioidomycosis - Arizona, 1990-1995. MMWR Morb Mortal Wkly Rep. 1996;45:1069-1073.

• 全文
• 摘要

29.  Ampel NM, Mosley DG, England B, et al. Coccidioidomycosis in Arizona: increase in incidence from 1990 to 1995. Clin Infect Dis. 1998;27:1528-1530.

• 摘要

30.  Centers for Disease Control and Prevention. Increase in coccidioidomycosis - Arizona, 1998-2001. MMWR Morb Mortal Wkly Rep. 2003;52:109-112.

• 摘要

31.  Ampel MA. Coccidiodomycosis in persons infected with HIV type 1. Clin Infect Dis. 2005;41:1174-1178.

• 全文
• 摘要

32.  Ampel NM, Dols CL, Galgiani JN. Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. Am J Med. 1993;94:235-240.

• 摘要

33.  Olmedo Diaz I, Pallas Alonso CR, Miralles Molina M, et al. Neonatal meningitis: study of 56 cases. An Esp Pediatr. 1997;46:189-194.

• 摘要

34.  Buchs S. Candida meningitis: a growing threat to premature and fullterm infants. Pediatr Infect Dis. 1985;4:122-123.

• 摘要

35.  Fernandez M, Moylett EH, Noyola DE, et al. Candidal meningitis in neonates: a 10-year review. Clin Infect Dis. 2000;31:458-463.

• 全文
• 摘要

36.  Lipton SA, Hickey WF, Morris JH, et al. Candidal infection in the central nervous system. Am J Med. 1984;76:101-108.

• 摘要

37.  Voice RA, Bradley SF, Sangeorzan JA, et al. Chronic candidal meningitis: an uncommon manifestation of candidiasis. Clin. Infect Dis. 1994;19:60-66.

• 摘要

38.  Chiou CC, Wong TT, Lin HH, et al. Fungal infection of ventriculoperitoneal shunts in children. Clin Infect Dis. 1994;19:1049-1053.

• 摘要

39.  Sanchez-Portocarrero J, Martin-Rabadan P, Saldana CJ, et al. Candida cerebrospinal fluid shunt infection. Report of two new cases and review of the literature. Diagn Microbiol Infect Dis. 1994;20:33-40.

• 摘要

40.  Nguyen MH, Yu VL. Meningitis caused by Candida species: an emerging problem in neurosurgical patients. Clin Infect Dis. 1995;21:323-327.

• 摘要

41.  Kainer MA, Reagan DR, Nguyen DB, et al; Tennessee Fungal Meningitis Investigation Team. Fungal infections associated with contaminated methylprednisolone in Tennessee. N Engl J Med. 2012;367:2194-2203.

• 全文
• 摘要

42.  Centers for Disease Control and Prevention (CDC). Multistate outbreak of fungal meningitis and other infections – case count. October 2015. http://www.cdc.gov (last accessed 31 August 2016).

• 全文

43.  Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin North Am. 2006;20:507-544.

• 摘要

44.  Sanchez-Portocarrero J, Perez-Cecilia E, Corral O, et al. The central nervous system and infection by Candida species. Diagn Microbiol Infect Dis. 2000;37:169-179.

• 摘要

45.  Antinori S, Corbellino M, Meroni L, et al. Aspergillus meningitis: a rare clinical manifestation of central nervous system aspergillosis - case report and review of 92 cases. J Infect. 2013;66:218-238.

• 摘要

46.  Harrison TS, Levitz SM. Immunology. In: Anaissie EJ, McGinnis MR, Pfaller MA, eds. Clinical mycology. New York, NY: Churchill Livingstone; 2003.

47.  Garcia-Hermoso D, Janbon G, Dromer F. Epidemiological evidence for dormant Cryptococcus neoformans infection. J Clin Microbiol. 1999;37:3204-3209.

• 全文
• 摘要

48.  Casadevall A, Steenbergen JN, Nosanchuk JD. 'Ready made' virulence and 'dual use' virulence factors in pathogenic environmental fungi - the Cryptococcus neoformans paradigm. Curr Opin Microbiol. 2003;6:332-337.

• 摘要

49.  McKinsey DS, Spiegel RA, Hutwagner L, et al. Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology. Clin Infect Dis. 1997;24:1195-1203.

• 摘要

50.  van der Horst C, Saag MS, Cloud GA, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med. 1997;337:15-21.

• 全文
• 摘要

51.  Pappas PG, Perfect JR, Cloud GA, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis. 2001;33:690-699.

• 全文
• 摘要

52.  Einstein HE, Johnson RH. Coccidioidomycosis: new aspects of epidemiology and therapy. Clin Infect Dis. 1993;16:349-354.

• 摘要

53.  Crum NF, Lederman ER, Stafford CM, et al. Coccidioidomycosis: a descriptive survey of a reemerging disease. Clinical characteristics and current controversies. Medicine (Baltimore). 2004;83:149-175.

• 摘要

54.  Casado JL, Quereda C, Oliva J, et al. Candidal meningitis in HIV-infected patients: analysis of 14 cases. Clin Infect Dis. 1997;25:673-676.

• 摘要

55.  del Pozo MM, Bermejo F, Molina JA, et al. Chronic neutrophilic meningitis caused by Candida albicans. Neurologia. 1998;13:362-366.

• 摘要

56.  Chang LW, Phipps WT, Kennedy GE, et al. Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV. Cochrane Database Syst Rev. 2005;(3):CD004773.

• 全文
• 摘要

57.  Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45:807-825.

• 全文
• 摘要

58.  Galgiani JN, Ampel NM, Blair JE, et al. 2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis. 2016;63:e112-e146.

• 全文
• 摘要

59.  Woods CW, McRill C, Plikaytis BD, et al. Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: incidence, risk factors, and prevention. J Infect Dis. 2000;181:1428-1434.

• 全文
• 摘要

60.  Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62:e1-e50.

• 全文
• 摘要

61.  Blyth CC, Barzi F, Hale K, Isaacs D. Chemoprophylaxis of neonatal fungal infections in very low birthweight infants: efficacy and safety of fluconazole and nystatin. J Paediatr Child Health. 2012;48:846-451.

• 摘要

62.  Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:291-322.

• 全文
• 摘要

63.  Muller M, Wandel S, Colebunders R, et al. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10:251-261.

• 摘要

64.  Bayer AS, Edwards JE, Seidel JS, et al. Candida meningitis. Report of seven cases and review of the English literature. Medicine (Baltimore). 1976;55:477-486.

• 摘要

65.  Yuanije Z, Jianghan C, Nan X, et al. Cryptococcal meningitis in immunocompetent children. Mycoses. 2012;55:168-171.

• 摘要

66.  Ashbee HR, Evans EG, Viviani MA, et al. Histoplasmosis in Europe: report on an epidemiological survey from the European Confederation of Medical Mycology Working Group. Med Mycol. 2008;46:57-65.

• 摘要

67.  Sharma P, Mukherjee A, Karunanithi S, et al. Potential role of 18F-FDG PET/CT in patients with fungal infections. AJR Am J Roentgenol. 2014;203:180-189.

• 摘要

68.  Chong GM, Maertens JA, Lagrou K, et al. Diagnostic performance of galactomannan antigen testing in cerebrospinal fluid. J Clin Microbiol. 2016;54:428-431.

• 全文
• 摘要

69.  Garber S, Penar P. Treatment of indolent, nonencapsulated cryptococcal meningitis associated with hydrocephalus. Clin Pract. 2012;2:e22.

• 全文
• 摘要

70.  Litvintseva AP, Lindsley MD, Gade L, et al. Utility of (1-3)-beta-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections. Clin Infect Dis. 2014;58:622-630.

• 摘要

71.  Brouwer AE, Rajanuwong A, Chierakul W, et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet. 2004;363:1764-1767.

• 摘要

72.  Centers for Disease Control and Prevention. Multistate outbreak of fungal meningitis and other infections: resources for laboratories. October 2015. http://www.cdc.gov (last accessed 31 August 2016).

• 全文

73.  Steiner I, Schmutzhard E, Sellner J, et al; European Federation of Neurological Sciences; European Neurologic Society. EFNS-ENS guidelines for the use of PCR technology for the diagnosis of infections of the nervous system. Eur J Neurol. 2012;19:1278-1291.

• 摘要

74.  Thwaites GE, Caws M, Chau TT, et al. Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy. J Clin Microbiol. 2004;42:996-1002.

• 全文
• 摘要

75.  Hamill RJ, Sobel JD, El-Sadr W, et al. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety. Clin Infect Dis. 2010;51:225-232.

• 全文
• 摘要

76.  Day JN, Chau TT, Wolbers M, et al. Combination antifungal therapy for cryptococcal meningitis. N Engl J Med. 2013;368:1291-1302.

• 全文
• 摘要

77.  Beardsley J, Wolbers M, Kibengo FM, et al; CryptoDex Investigators. Adjunctive dexamethasone in HIV-associated cryptococcal meningitis. N Engl J Med. 2016;374:542-554.

• 全文
• 摘要

78.  Kaplan JE, Masur H, Holmes KK; USPHS; Infectious Disease Society of America. Guidelines for preventing opportunistic infections among HIV-infected persons - 2002. MMWR Recomm Rep. 2002 Jun 14;51(RR-8):1-52.

• 全文
• 摘要

79.  Saag MS, Cloud GA, Graybill JR, et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. Clin Infect Dis. 1999;28:291-296.

• 全文
• 摘要

80.  Powderly WG, Saag MS, Cloud GA, et al. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992:326:793-798.

• 摘要

81.  Mdodo R, Moser SA, Jaoko W, et al. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates from AIDS patients in Kenya. Mycoses. 2011;54:e438-e442.

• 摘要

82.  Boulware DR, Meya DB, Muzoora C, et al; COAT Trial Team. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. N Engl J Med. 2014;370:2487-2498.

• 全文
• 摘要

83.  Graybill JR, Sobel J, Saag M, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. Clin Infect Dis. 2000;30:47-54.

• 全文
• 摘要

84.  Macsween KF, Bicanic T, Brouwer AE, et al. Lumbar drainage for control of cerebrospinal fluid pressure in cryptococcal meningitis: case report and review. J Infect. 2005;51:e221-e224.

• 摘要

85.  Johnson PC, Wheat LJ, Cloud GA, et al; National Institute of Allergy and Infectious Diseases Mycoses Study Group. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med. 2002;137:105-109.

• 全文
• 摘要

86.  Groll AH, Giri N, Petraitis V, et al. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. J Infect Dis. 2000;182:274-282.

• 全文
• 摘要

87.  Goldman M, Zackin R, Fichtenbaum CJ, et al. Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. Clin Infect Dis. 2004;38:1485-1489.

• 全文
• 摘要

88.  Galgiani JN, Catanzaro A, Cloud GA, et al. Fluconazole therapy for coccidioidal meningitis. The NIAID-Mycoses Study Group. Ann Intern Med. 1993;119:28-35.

• 摘要

89.  Restrepo A, Tobon A, Clark B, et al. Salvage treatment of histoplasmosis with posaconazole. J Infect. 2007;54:319-327.

• 摘要

90.  Cortez KJ, Walsh TJ, Bennett JE. Successful treatment of coccidioidal meningitis with voriconazole. Clin Infect Dis. 2003;36:1619-1622.

• 全文
• 摘要

91.  Proia LA, Tenorio AR. Successful use of voriconazole for treatment of Coccidioides meningitis. Antimicrob Agents Chemother. 2004;48:2341-2343.

• 全文
• 摘要

92.  Centers for Disease Control and Prevention. Multistate outbreak of fungal meningitis and other infections: resources for clinicians. October 2015. http://www.cdc.gov (last accessed 31 August 2016).

• 全文

93.  Smith RM, Tipple M, Chaudry MN, et al. Relapse of fungal meningitis associated with contaminated methylprednisolone. N Engl J Med. 2013;368:2535-2536.

• 全文
• 摘要

94.  Patterson TF, Thompson GR 3rd, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63:e1-e60.

• 全文
• 摘要

95.  Dan M. Mucormycosis of the head and neck. Curr Infect Dis Rep. 2011;13:123-131.

• 摘要

96.  Branch RA. Prevention of amphotericin B-induced renal impairment. A review on the use of sodium supplementation. Arch Intern Med. 1988;148:2389-2394.

• 摘要

97.  Bicanic T, Wood R, Meintjes G, et al. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. Clin Infect Dis. 2008;47:123-130.

• 全文
• 摘要

98.  Stevens DA, Shatsky SA. Intrathecal amphotericin in the management of coccidioidal meningitis. Semin Respir Infect. 2001;16:263-269.

• 摘要

99.  Kambugu AD, Kamya M, Mayanja-Kizza H, et al. The high mortality of HIV associated Cryptococcal meningitis despite high dose amphotericin B therapy in Uganda. 41st Annual Meeting of The Infectious Diseases Society of America. San Diego, 2003. Abstract 629.

100.  Imwidthaya P, Poungvarin N. Cryptococcosis in AIDS. Postgrad Med J. 2000;76:85-88.

• 摘要

101.  Lu CH, Chen HL, Chang WN, et al. Assessing the chronic neuropsychologic sequelae of human immunodeficiency virus-negative cryptococcal meningitis by using diffusion tensor imaging. AJNR Am J Neuroradiol. 2011;32:1333-1339.

• 全文
• 摘要

102.  Dewsnup DH, Galgiani JN, Graybill JR, et al. Is it ever safe to stop azole therapy for Coccidioides immitis meningitis? Ann Intern Med. 1996;124:305-310.

• 摘要

103.  Lee BE, Cheung PY, Robinson JL, et al. Comparative study of mortality and morbidity in premature infants (birth weight <1.250 g) with candidaemia or candidal meningitis. Clin Infect Dis. 1998;27:559-565.

• 摘要

104.  Buchs S, Pfister P. Candida meningitis. Course, prognosis and mortality before and after introduction of the new antimycotics. Mykosen. 1983;26:73-81.

• 摘要

105.  Porter SD, Noble MA, Rennie R. A single strain of Candida albicans associated with separate episodes of fungemia and meningitis. J Clin Microbiol 1996;34:1813-1814.

• 全文
• 摘要

106.  Shelburne SA 3rd, Darcourt J, White AC Jr, et al. The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40:1049-1052.

• 全文
• 摘要

107.  Lortholary O, Sitbon K, Dromer F; French Cryptococcosis Study Group. Evidence for human immunodeficiency virus and Cryptococcus neoformans interactions in the pro-inflammatory and anti-inflammatory responses in blood during AIDS-associated cryptococcosis. Clin Microbiol Infect. 2005;11:296-300.

• 全文
• 摘要

108.  Lawn SD, Bekker LG, Myer L, et al. Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme. AIDS. 2005;19:2050-2052.

• 摘要

109.  Berkeley JL, Nath A, Pardo CA. Fatal immune reconstitution inflammatory syndrome with human immunodeficiency virus infection and Candida meningitis: case report and review of the literature. J Neurovirol. 2008;14:267-276.

• 摘要